Plain-English translation of NCT06692361 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether fecal microbiota transplantation (FMT)—capsules containing healthy bacteria from donor stool—can help people with major depression whose symptoms haven't improved well enough after starting an antidepressant called escitalopram oxalate. You would continue taking your antidepressant while also receiving either the FMT capsules or a placebo (dummy capsules) for 4 weeks, then be followed for 20 additional weeks to see if this combination works better than medication alone.
Many people with depression don't respond fully to standard antidepressant medications, leaving them still struggling with their symptoms. Recent research suggests that the bacteria in our gut may influence mood and mental health, so doctors are investigating whether restoring a healthy balance of gut bacteria might improve depression that hasn't responded well to medication alone.
You likely qualify if…
You likely don't qualify if…
First, you would be screened and take an antidepressant called escitalopram for 2 weeks to see how you respond. If your depression doesn't improve enough, you would be randomly assigned to either continue your antidepressant plus take FMT capsules, or continue your antidepressant plus take placebo capsules, for 4 weeks. After that, you would return for follow-up visits and assessments over the next 20 weeks to measure how well the treatment worked. The study involves depression rating scales to track your symptoms throughout.
AI-generated summary from trial data · Jul 14, 2026 · Not medical advice
China